This inventor holds 15 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Banyu Pharmaceutical Co. Ltd, Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai, Microbial Chemistry Research Foundation. Active years: 1977-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JA (1977)
- Tokyo, JP (1980 - 1996)
Company Filing History:
Years Active: 1977-1996
Areas of Expertise:
Title: Hajime Morishima: Innovator in N-Acylamino Acid Derivatives
Introduction
Hajime Morishima is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of chemistry, particularly in the development of N-acylamino acid derivatives. With a total of 15 patents to his name, Morishima's work has had a notable impact on the pharmaceutical industry.
Latest Patents
Morishima's latest patents focus on N-acylamino acid derivatives and their applications. These derivatives are characterized by complex chemical structures that include various functional groups. His innovative formulations are designed to be useful as hypotensive drugs, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Morishima has worked with several notable companies, including Banyu Pharmaceutical Co. Ltd and Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in his field.
Collaborations
Some of Morishima's notable coworkers include Masato Nakano and Shugo Atsuumi. Their collaborative efforts have further enhanced the quality and scope of the research conducted in the realm of N-acylamino acid derivatives.
Conclusion
Hajime Morishima's contributions to the field of chemistry and his innovative patents have established him as a key figure in the development of new pharmaceutical solutions. His work continues to influence the industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile